EWM
CRL icon

EPG Wealth Management’s Charles River Laboratories CRL Stock Holding History

EPG Wealth Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-55
Closed -$7K – 257
2020
Q1 		$7K Hold
55
– – 0.01% 529
2019
Q4 		$8K Buy
+55
New +$7.62K 0.01% 446

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

EPG Wealth Management's CRL Position: Q2 2020 in Review

EPG Wealth Management sold out of Charles River Laboratories (CRL) in Q2 2020, closing a stake of 55 shares — an estimated $7K sold.

EPG Wealth Management first reported a position in CRL in Q4 2019 and held it in 2 quarters. The position peaked at $8K in Q4 2019. 466 funds tracked by Wall St. Rank hold CRL as of Q2 2020.

  • EPG Wealth Management reported no remaining Charles River Laboratories position as of Q2 2020 after selling out during the quarter.
  • EPG Wealth Management sold 55 Charles River Laboratories shares in Q2 2020, an estimated $7K.
  • EPG Wealth Management first reported a position in Charles River Laboratories in Q4 2019 and held it in 2 quarters.
  • EPG Wealth Management's Charles River Laboratories position peaked at $8K in Q4 2019.
  • 466 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2020.

Based on EPG Wealth Management's 13F filing for Q2 2020, filed 6 Aug 2020.